Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BMRA vs $CTSO | Chartloom

Compare

$BMRA vs $CTSO

Biomerica Inc · Cytosorbents Corp

BMRA

Biomerica Inc

CTSO

Cytosorbents Corp

Compare $BMRA vs $CTSO

Comparing Biomerica Inc and Cytosorbents Corp

BMRABiomerica Inc

CTSOCytosorbents Corp

BMRABiomerica Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-16.2%

YTD performance

-26.9%

52W performance

-34.6%

FCF yield

-60.5%

CTSOCytosorbents Corp

Market cap

$217M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.02x

Rev growth (TTM)

8.6%

YTD performance

-73.6%

52W performance

-81.1%

FCF yield

-4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BMRA

CTSO

Detailed metrics comparison

BMRA

Biomerica Inc

CTSO

Cytosorbents Corp

Market Cap

BMRA$6M

CTSO$217M

Enterprise Value

BMRA$5M

CTSO$230M

Price

BMRA$1.85

CTSO$3.46

P/E Ratio

BMRAN/A

CTSON/A

P/S Ratio

BMRA1.28x

CTSO5.84x

EV/Sales

BMRA1.10x

CTSO6.19x

EV/EBITDA

BMRA29.35x

CTSO0.00x

P/B Ratio

BMRA3.21x

CTSO5.44x

P/FCF Ratio

BMRAN/A

CTSON/A

EV/FCF

BMRA-1.42x

CTSO-23.75x

PEG Ratio

BMRAN/A

CTSON/A

Forward P/E (NTM)

BMRAN/A

CTSON/A

Forward P/S (NTM)

BMRAN/A

CTSO5.02x

Revenue (TTM)

BMRA$4M

CTSO$37M

Revenue Growth (YoY)

BMRA-16.2%

CTSO8.6%

Forward Rev Growth

BMRA0.0%

CTSO13.6%

Gross Margin (TTM)

BMRA8.1%

CTSO71.6%

Operating Margin (TTM)

BMRA0.0%

CTSO0.0%

EBITDA Margin (TTM)

BMRA-117.8%

CTSO-28.3%

Net Margin (TTM)

BMRA-84.8%

CTSO-48.9%

FCF Margin (TTM)

BMRA-77.7%

CTSO-26.0%

Net Income (TTM)

BMRA$-4M

CTSO$-18M

FCF (TTM)

BMRA$-3M

CTSO$-10M

EPS (TTM)

BMRA-$1.22

CTSO-$0.29

ROE (TTM)

BMRA-9719.0%

CTSO-16513.0%

ROA (TTM)

BMRA-6157.0%

CTSO-4325.0%

ROIC (TTM)

BMRA-9416.0%

CTSO-5193.0%

Cash

BMRA$1M

CTSO$4M

Debt

BMRA$500K

CTSO$17M

Net Cash/Debt

BMRA$808K

CTSO$-13M

Current Ratio (TTM)

BMRA1.62x

CTSO0.66x

Quick Ratio (TTM)

BMRA0.84x

CTSO0.47x

Debt/Equity (TTM)

BMRA0.19x

CTSO7.73x

Debt/Assets (TTM)

BMRA0.0%

CTSO0.0%

Interest Coverage (TTM)

BMRAN/A

CTSON/A

Net Debt/EBITDA (TTM)

BMRA0.00x

CTSO0.00x

Beta

BMRA0.39

CTSO1.51

52W Performance

BMRA-34.6%

CTSO-81.1%

YTD Performance

BMRA-26.9%

CTSO-73.6%

% from 52W High

BMRA-42.4%

CTSO-82.5%

% from 52W Low

BMRA27.6%

CTSO1.1%

Asset Turnover (TTM)

BMRA0.73x

CTSO0.88x

FCF Yield (TTM)

BMRA-60.5%

CTSO-4.5%

Earnings Yield (TTM)

BMRA-66.0%

CTSO-8.4%

Dividend Yield (TTM)

BMRAN/A

CTSON/A

Rule of 40

BMRA-93.8

CTSO-17.4

EV/GP/RG

BMRAN/A

CTSO0.53

Ticker research

View BMRA research View CTSO research

Metric	BMRA Biomerica Inc	CTSO Cytosorbents Corp
Market & Valuation
Market Cap	$6M	$217M
Enterprise Value	$5M	$230M
Price	$1.85	$3.46
P/E Ratio	N/A	N/A
P/S Ratio	1.28x	5.84x
EV/Sales	1.10x	6.19x
EV/EBITDA	29.35x	0.00x
P/B Ratio	3.21x	5.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.42x	-23.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.02x
Revenue & Growth
Revenue (TTM)	$4M	$37M
Revenue Growth (YoY)	-16.2%	8.6%
Forward Rev Growth	0.0%	13.6%
Profitability
Gross Margin (TTM)	8.1%	71.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-117.8%	-28.3%
Net Margin (TTM)	-84.8%	-48.9%
FCF Margin (TTM)	-77.7%	-26.0%
Net Income (TTM)	$-4M	$-18M
FCF (TTM)	$-3M	$-10M
EPS (TTM)	-$1.22	-$0.29
ROE (TTM)	-9719.0%	-16513.0%
ROA (TTM)	-6157.0%	-4325.0%
ROIC (TTM)	-9416.0%	-5193.0%
Financial Health
Cash	$1M	$4M
Debt	$500K	$17M
Net Cash/Debt	$808K	$-13M
Current Ratio (TTM)	1.62x	0.66x
Quick Ratio (TTM)	0.84x	0.47x
Debt/Equity (TTM)	0.19x	7.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	1.51
52W Performance	-34.6%	-81.1%
YTD Performance	-26.9%	-73.6%
% from 52W High	-42.4%	-82.5%
% from 52W Low	27.6%	1.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.88x
FCF Yield (TTM)	-60.5%	-4.5%
Earnings Yield (TTM)	-66.0%	-8.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-93.8	-17.4
EV/GP/RG	N/A	0.53
Ticker research	View BMRA research	View CTSO research

Valuation

P/S Ratio

BMRA

1.28x

CTSO

5.84x

EV/FCF

CTSO

-23.75x

BMRA

-1.42x

Growth & revenue

Revenue Growth TTM

CTSO

8.6%

BMRA

-16.2%

Forward Revenue Growth

CTSO

13.6%

BMRA

0.0%

Profitability & performance

Gross Margin

CTSO

71.6%

BMRA

8.1%

ROE

BMRA

-9719.0%

CTSO

-16513.0%

FCF Yield %

CTSO

-4.5%

BMRA

-60.5%

52-Week Performance

BMRA

-34.6%

CTSO

-81.1%

Detailed metrics comparison

BMRA

Biomerica Inc

CTSO

Cytosorbents Corp

Market Cap

BMRA$6M

CTSO$217M

Enterprise Value

BMRA$5M

CTSO$230M

Price

BMRA$1.85

CTSO$3.46

P/E Ratio

BMRAN/A

CTSON/A

P/S Ratio

BMRA1.28x

CTSO5.84x

EV/Sales

BMRA1.10x

CTSO6.19x

EV/EBITDA

BMRA29.35x

CTSO0.00x

P/B Ratio

BMRA3.21x

CTSO5.44x

P/FCF Ratio

BMRAN/A

CTSON/A

EV/FCF

BMRA-1.42x

CTSO-23.75x

PEG Ratio

BMRAN/A

CTSON/A

Forward P/E (NTM)

BMRAN/A

CTSON/A

Forward P/S (NTM)

BMRAN/A

CTSO5.02x

Revenue (TTM)

BMRA$4M

CTSO$37M

Revenue Growth (YoY)

BMRA-16.2%

CTSO8.6%

Forward Rev Growth

BMRA0.0%

CTSO13.6%

Gross Margin (TTM)

BMRA8.1%

CTSO71.6%

Operating Margin (TTM)

BMRA0.0%

CTSO0.0%

EBITDA Margin (TTM)

BMRA-117.8%

CTSO-28.3%

Net Margin (TTM)

BMRA-84.8%

CTSO-48.9%

FCF Margin (TTM)

BMRA-77.7%

CTSO-26.0%

Net Income (TTM)

BMRA$-4M

CTSO$-18M

FCF (TTM)

BMRA$-3M

CTSO$-10M

EPS (TTM)

BMRA-$1.22

CTSO-$0.29

ROE (TTM)

BMRA-9719.0%

CTSO-16513.0%

ROA (TTM)

BMRA-6157.0%

CTSO-4325.0%

ROIC (TTM)

BMRA-9416.0%

CTSO-5193.0%

Cash

BMRA$1M

CTSO$4M

Debt

BMRA$500K

CTSO$17M

Net Cash/Debt

BMRA$808K

CTSO$-13M

Current Ratio (TTM)

BMRA1.62x

CTSO0.66x

Quick Ratio (TTM)

BMRA0.84x

CTSO0.47x

Debt/Equity (TTM)

BMRA0.19x

CTSO7.73x

Debt/Assets (TTM)

BMRA0.0%

CTSO0.0%

Interest Coverage (TTM)

BMRAN/A

CTSON/A

Net Debt/EBITDA (TTM)

BMRA0.00x

CTSO0.00x

Beta

BMRA0.39

CTSO1.51

52W Performance

BMRA-34.6%

CTSO-81.1%

YTD Performance

BMRA-26.9%

CTSO-73.6%

% from 52W High

BMRA-42.4%

CTSO-82.5%

% from 52W Low

BMRA27.6%

CTSO1.1%

Asset Turnover (TTM)

BMRA0.73x

CTSO0.88x

FCF Yield (TTM)

BMRA-60.5%

CTSO-4.5%

Earnings Yield (TTM)

BMRA-66.0%

CTSO-8.4%

Dividend Yield (TTM)

BMRAN/A

CTSON/A

Rule of 40

BMRA-93.8

CTSO-17.4

EV/GP/RG

BMRAN/A

CTSO0.53

Ticker research

View BMRA research View CTSO research

Metric	BMRA Biomerica Inc	CTSO Cytosorbents Corp
Market & Valuation
Market Cap	$6M	$217M
Enterprise Value	$5M	$230M
Price	$1.85	$3.46
P/E Ratio	N/A	N/A
P/S Ratio	1.28x	5.84x
EV/Sales	1.10x	6.19x
EV/EBITDA	29.35x	0.00x
P/B Ratio	3.21x	5.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.42x	-23.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.02x
Revenue & Growth
Revenue (TTM)	$4M	$37M
Revenue Growth (YoY)	-16.2%	8.6%
Forward Rev Growth	0.0%	13.6%
Profitability
Gross Margin (TTM)	8.1%	71.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-117.8%	-28.3%
Net Margin (TTM)	-84.8%	-48.9%
FCF Margin (TTM)	-77.7%	-26.0%
Net Income (TTM)	$-4M	$-18M
FCF (TTM)	$-3M	$-10M
EPS (TTM)	-$1.22	-$0.29
ROE (TTM)	-9719.0%	-16513.0%
ROA (TTM)	-6157.0%	-4325.0%
ROIC (TTM)	-9416.0%	-5193.0%
Financial Health
Cash	$1M	$4M
Debt	$500K	$17M
Net Cash/Debt	$808K	$-13M
Current Ratio (TTM)	1.62x	0.66x
Quick Ratio (TTM)	0.84x	0.47x
Debt/Equity (TTM)	0.19x	7.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.39	1.51
52W Performance	-34.6%	-81.1%
YTD Performance	-26.9%	-73.6%
% from 52W High	-42.4%	-82.5%
% from 52W Low	27.6%	1.1%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.88x
FCF Yield (TTM)	-60.5%	-4.5%
Earnings Yield (TTM)	-66.0%	-8.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-93.8	-17.4
EV/GP/RG	N/A	0.53
Ticker research	View BMRA research	View CTSO research